The research profile for Prelude Therapeutics reflects the articles published from the 145 journals included in the Nature Index during a 12-month rolling window.

The new Prelude is expected to hit dealers in Japan, Europe, and North America this fall. Furthermore, it has now been confirmed that the hybrid coupe will reach Australia in mid-2026.